论文部分内容阅读
目的探讨分析莫沙必利联合舒肝解郁胶囊治疗功能性消化不良的效果。方法 122例功能性消化不良患者,随机分为观察组和对照组,各61例。观察组采用莫沙必利联合舒肝解郁胶囊治疗,对照组单独采用莫沙必利治疗,观察比较两组患者临床效果。结果观察组治疗总有效率93.44%明显高于对照组80.33%,差异有统计学意义(χ~2=4.604,P<0.05)。观察组疾病复发率6.56%明显低于对照组24.59%,差异有统计学意义(χ~2=7.543,P<0.05)。两组患者不良反应发生率比较,差异无统计学意义(χ~2=0.535,P>0.05)。结论莫沙必利联合舒肝解郁胶囊治疗功能性消化不良临床治疗效果较好,疾病复发率低,具有较高的安全性,值得临床推广。
Objective To investigate the effect of Mosapride combined with Shugan Jieyu capsule on functional dyspepsia. Methods 122 patients with functional dyspepsia were randomly divided into observation group and control group, with 61 cases in each group. The observation group was treated with mosapride combined with Shugan Jieyu capsule. The control group was treated with mosapride alone, and the clinical effects were observed and compared between the two groups. Results The total effective rate of observation group was 93.44%, which was significantly higher than that of the control group (80.33%) (χ ~ 2 = 4.604, P <0.05). The rate of disease recurrence in observation group was significantly lower than that in control group (6.56% vs 24.59%, χ ~ 2 = 7.543, P <0.05). There was no significant difference in the incidence of adverse reactions between the two groups (χ ~ 2 = 0.535, P> 0.05). Conclusion Mosapride combined with Shugan Jieyu capsule is effective in treating functional dyspepsia, with low recurrence rate and high safety. It is worthy of clinical promotion.